AVERITAS
Live / Registered — Registered (as of 22 Apr 2025)
What this means for you
Registered since 22 Apr 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97978838
- Registration number
- 7771071
- Mark type
- Stylized text
- Filed
- 15 Dec 2022
- Published for opposition
- 28 Mar 2023
- Registered
- 22 Apr 2025
- Attorney of record
- Paul C. Llewellyn
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, and neurological diseases and disorders
Owner
- Averitas Pharma, Inc., Morristown, NJ, US
- Averitas Pharma, Inc., Morristown, NJ, US
- Averitas Pharma, Inc., Morristown, NJ, US
Prior registrations
Prosecution history
- 22 Apr 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 22 Apr 2025 — REGISTERED-PRINCIPAL REGISTER
- 02 Apr 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 02 Apr 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 01 Apr 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 01 Apr 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 01 Apr 2025 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 21 Mar 2025 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 21 Mar 2025 — FINAL REFUSAL E-MAILED
- 21 Mar 2025 — SU - FINAL REFUSAL - WRITTEN
- 14 Mar 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 14 Mar 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 15 Mar 2025 — ASSIGNED TO LIE
- 05 Mar 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 20 Nov 2024 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED